PharmiNews

Directory of Pharma Companies and News

Company Profile

Azeria Therapeutics

Azeria Therapeutics logo
Category
Azeria Therapeutics is the world’s first pioneer factor drug discovery company developing breakthrough treatments for hormone resistant breast and prostate cancer patients where there are significant areas of unmet clinical need. Founded in 2017 by the leading expert in pioneer factors in cancer, Dr Jason Carroll, Azeria is using its proprietary drug screening platform to develop a pipeline of small molecules designed to identify selective pioneer factor inhibitors. Based in Cambridge, Azeria successfully raised £4 million in a Series A financing in 2018, provided by specialist oncology investment fund, the CRT Pioneer Fund, managed by Sixth Element Capital.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma